These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19010142)

  • 1. Association between serum soluble CD30 and serum creatinine before and after renal transplantation.
    López-Hoyos M; San Segundo D; Benito MJ; Fernández-Fresnedo G; Ruiz JC; Rodrigo E; Gómez-Alamillo C; Benito A; Arias M
    Transplant Proc; 2008 Nov; 40(9):2903-5. PubMed ID: 19010142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Level of soluble CD30 after kidney transplantation correlates with acute rejection episodes.
    Yang JL; Hao HJ; Zhang B; Liu YX; Chen S; Na YQ
    Transplant Proc; 2008 Dec; 40(10):3381-3. PubMed ID: 19100394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transplant increased levels of serum sCD30 is a marker for prediction of kidney allograft loss in a 5-year prospective study.
    Delgado JC; Pavlov IY; Shihab FS
    Transpl Immunol; 2009 Dec; 22(1-2):1-4. PubMed ID: 19772921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial soluble CD30 measurements as a predictor of kidney graft outcome.
    Halim MA; Al-Otaibi T; Al-Muzairai I; Mansour M; Tawab KA; Awadain WH; Balaha MA; Said T; Nair P; Nampoory MR
    Transplant Proc; 2010 Apr; 42(3):801-3. PubMed ID: 20430176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High variation of individual soluble serum CD30 levels of pre-transplantation patients: sCD30 a feasible marker for prediction of kidney allograft rejection?
    Altermann W; Schlaf G; Rothhoff A; Seliger B
    Nephrol Dial Transplant; 2007 Oct; 22(10):2795-9. PubMed ID: 17616534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum soluble CD30 does not predict acute rejection in liver transplant patients.
    Matinlauri I; Höckerstedt K; Isoniemi H
    Transplant Proc; 2006 Dec; 38(10):3601-4. PubMed ID: 17175343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does pretransplant soluble CD30 serum concentration affect deceased-donor kidney graft function 3 years after transplantation?
    Kovac J; Arnol M; Vidan-Jeras B; Bren AF; Kandus A
    Transplant Proc; 2008 Jun; 40(5):1357-61. PubMed ID: 18589105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD30 and Cd27 levels in patients undergoing HLA antibody-incompatible renal transplantation.
    Hamer R; Roche L; Smillie D; Harmer A; Mitchell D; Molostvov G; Lam FT; Kashi H; Tan LC; Imray C; Fletcher S; Briggs D; Lowe D; Zehnder D; Higgins R
    Transpl Immunol; 2010 Aug; 23(4):161-5. PubMed ID: 20600903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of pre- and posttransplantation serum interferon-gamma and soluble CD30 for predicting liver allograft rejection.
    Kim KH; Oh EJ; Jung ES; Park YJ; Choi JY; Kim DG; Lee KY; Kang CS
    Transplant Proc; 2006 Jun; 38(5):1429-31. PubMed ID: 16797323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TH1/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion.
    Solgi G; Amirzagar AA; Pourmand G; Mehrsai AR; Taherimahmoudi M; Baradaran N; Nicknam MH; Ebrahimi Rad MR; Saraji A; Asadpoor AA; Moheiydin M; Nikbin B
    Transplant Proc; 2009 Sep; 41(7):2800-4. PubMed ID: 19765439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High pretransplantation soluble CD30 levels: impact in renal transplantation.
    Giannoli C; Bonnet MC; Perrat G; Houillon A; Reydet S; Pouteil-Noble C; Villar E; Lefrançois N; Morelon E; Dubois V
    Transplant Proc; 2007 Oct; 39(8):2574-5. PubMed ID: 17954178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection.
    Ayed K; Abdallah TB; Bardi R; Abderrahim E; Kheder A
    Transplant Proc; 2006 Sep; 38(7):2300-2. PubMed ID: 16980071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretransplant soluble CD30 level has limited effect on acute rejection, but affects graft function in living donor kidney transplantation.
    Kim MS; Kim HJ; Kim SI; Ahn HJ; Ju MK; Kim HJ; Jeon KO; Kim YS
    Transplantation; 2006 Dec; 82(12):1602-5. PubMed ID: 17198243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD30, a marker to detect the high-risk kidney transplant recipients.
    Spiridon C; Nikaein A; Lerman M; Hunt J; Dickerman R; Mack M
    Clin Transplant; 2008; 22(6):765-9. PubMed ID: 19040559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement.
    Truong DQ; Darwish AA; Gras J; Wieërs G; Cornet A; Robert A; Mourad M; Malaise J; de Ville de Goyet J; Reding R; Latinne D
    Transpl Immunol; 2007 Jun; 17(4):283-7. PubMed ID: 17493532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of pretransplant immunologic status in kidney-transplant recipients by panel reactive antibody and soluble CD30 determinations.
    Cinti P; Pretagostini R; Arpino A; Tamburro ML; Mengasini S; Lattanzi R; De Simone P; Berloco P; Molajoni ER
    Transplantation; 2005 May; 79(9):1154-6. PubMed ID: 15880060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD30 as a prognostic factor for outcome following renal transplantation.
    Platt RE; Wu KS; Poole K; Newstead CG; Clark B
    J Clin Pathol; 2009 Jul; 62(7):662-3. PubMed ID: 19561239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
    Kamali K; Abbasi MA; Farokhi B; Abbasi A; Fallah P; Seifee MH; Ghadimi N; Rezaie AR
    Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of patients at risk of acute rejection by pretransplantation and posttransplantation monitoring of soluble CD30 levels in kidney transplantation.
    Sengul S; Keven K; Gormez U; Kutlay S; Erturk S; Erbay B
    Transplantation; 2006 Apr; 81(8):1216-9. PubMed ID: 16641611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble CD30 in renal transplant recipients: is it a good biomarker to predict rejection?
    Azarpira N; Aghdaie MH; Malekpour Z
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):31-6. PubMed ID: 20061689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.